All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news


← First12345...818Next →

hiv & aids news selected from other sources

  • Adherence
    Fixed-dose regimes ‘modestly’ lower risk of HIV treatment failure
    Avert | 15 December 2017

    New research compares treatment outcomes of single versus multiple tablet regimes, raising questions around cost-effectiveness.

  • Kidney problems
    Shift in HIV-Associated Kidney Disease Characterized
    Renal & Urology News | 15 December 2017

    Successful antiretroviral therapy for human immunodeficiency virus (HIV) infection has altered the spectrum of HIV-associated kidney disease over the past 30 years, according to the authors of a new review published in the New England Journal of Medicine.

  • Families and children
    UNICEF warns, the global HIV response is failing children and adolescents
    Avert | 15 December 2017

    Unless the HIV response is stepped up, we will not end AIDS in children and adolescents. This is the stark message in a new UNICEF report, released earlier this month.

  • Condoms and lubricant
    Almost half of under 25s 'never use a condom with a new partner'
    BBC Health | 15 December 2017

    Public Health England launches a new campaign to get more people thinking about using condoms.

  • PrEP
    The US Could Easily Hit Its 2020 HIV Prevention Goal By Using One Drug, Drexel Study Finds
    Drexel Now | 13 December 2017

    If just a quarter of men who have same-sex intercourse and are at a high risk for HIV used daily preventive medicine, three out of every 10 HIV infections could be averted, according to a new Drexel University study.

  • Outcomes and prognosis
    South Africa’s HIV treatment programme: a phoenix rising from the ashes?
    Ground Up | 13 December 2017

    In our most recent modelling study, published this week in PLoS Medicine, we have attempted to look back on what the ART programme has achieved to date – and what could have been achieved. It’s too soon to say whether progress reducing AIDS deaths has stalled, but the early signs suggest that this may be the new reality in the post-2014 period.

  • Bad science and bogus treatments
    Fingerprints of Russian Disinformation: From AIDS to Fake News
    New York Times | 13 December 2017

    Called Operation Infektion by the East German foreign intelligence service, the 1980s disinformation campaign seeded a conspiracy theory that the virus that causes AIDS was the product of biological weapons experiments conducted by the United States.

  • Treatment guidelines
    Transition to dolutegravir cost-effective in LMICs with high HIV drug resistance
    Healio | 13 December 2017

    In low- and middle-income countries, resistance to non-nucleoside reverse transcriptase inhibitors, or NNRTIs, is nearing and exceeding 10% in patients with HIV who are initiating or reinitiating first-line ART, according to recent data. A new modeling study showed that transitioning first-line ART from NNRTIs to dolutegravir may be a cost-effective way to reverse this increasing trend in resistance.

  • The search for a cure
    Frontiers of HIV Research: The Man Who Was Nearly Cured
    KQED | 13 December 2017

    “The whole excitement around Clark is that we were able to initiate therapy so early that we were hoping to prevent the establishing of latency,” says Deeks. “But it did not happen. We got close; we may have been off by a day or two. We did not achieve a real cure.”

  • PrEP
    Many young US men at high risk for HIV do not take anti-HIV pill
    Reuters | 13 December 2017

    Less than 4 percent of young adult men-who-have-sex-with-men in the U.S. – a population at significant risk of contracting the human immunodeficiency virus (HIV) – reported ever using the pill that protects them from the virus, in a recently published study.

← First12345...13Next →

Conference news

News from the 16th European AIDS Conference (EACS 2017).

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Achieving the 90-90-90 target

With advances in HIV testing, treatment and care, some countries are making great progress towards the UNAIDS 90-90-90 target.

New EUROBulletin

Read the December edition of the Sexual Health & HIV Policy EUROBulletin.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.